| BEFORE
THE CAMPAIGN: Uses.
Septrin is an antibacterial agent.
Septrin is effective in vitro
against a wide range of Gram-positive and
Gram-negative organisms. It is not active
against Mycobacterium tuberculosis.
Mycoplasma or Treponema
pallidium. Pseudomonas
aeruginosa is usually insensitive.
Septrin
is of value in the treatment of the
following:
Respiratory
tract: Acute and chronic bronchitis,
bronchiectasis, lobar and
broncho-pneumonia, otitis media.
sinusitis and prevention and treatment of
Pneumocystis carinii
pneumonitis.
Genito-urinary
tract: Acute upper and lower urinary
tract infections, bacterial prostatitis
and male and female gonorrhoea.
Gastro-intestinal
tract: Typhoid and paratyphoid
fevers, chronic carriage of Salmonella
typhi and paratyphi,
cholera as an adjunct to fluid and
electrolyte replacement and shigellosis.
Skin
infections: Pyoderma, abcesses and
wound infections.
Other
bacterial infections: Acute and
chronic osteomyelitis, acute brucellosis,
septicaemias and other infections caused
by sensitive organisms.
|
AFTER
THE CAMPAIGN: Uses.
Septrin should only be used where, in the
judgement of the physician, the benefits
of treatment outweigh any possible risks;
consideration should be given to the use
of a single effective antibacterial
agent.
The
in vitro susceptibility of bacteria to
antibiotics varies geographically and
with time; the local situation should
always be considered when selecting
antibiotic therapy.
Treatment
and prevention of Pneumocystis
carinii pneumonitis (see Dosage and
administration and Side- and adverse
effects).
Treatment
and prophylaxis of toxoplasmosis,
treatment of nocardiosis.
Urinary
tract infections; Acute uncomplicated
urinary tract infections: Treatment
of urinary tract infections where there
is bacterial evidence of sensitivity to
co-trimoxazole and good reason to prefer
this combination to a single antibiotic.
Respiratory
tract infections; Otitis media: Acute
treatment of otitis media, where there is
good reason to prefer co-trimoxazole to a
single antibiotic.
Treatment
of acute exacerbations of chronic
bronchitis, where there is bacterial
evidence of sensitivity to co-trimoxazole
and good reason to prefer this
combination to a single antibiotic.
|